View full meeting coverage »

Eyetube Meeting Coverage:

ASRS 2020



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Demographics in PANORAMA Patients

  Channels: Retina | Posted 8/3/2020

Nathan Steinle, MD, reviews data from the phase 3 PANORAMA study trials, which evaluated aflibercept (Eylea, Regeneron) for the treatment of nonproliferative diabetic retinopathy. Dr. Steinle analyzes the demographics of patients at the 52-week and 100-week timepoints to see if any baseline characteristics correlated with treatment outcomes.

aflibercept • Clinical Trials • Diabetic Retinopathy • retina-meeting-recap

1 / 10 Series: ASRS 2020